Fundraising FoxNuPulseCV
Raleigh, US · Founded 2010 · Delaware corporation · 1 known investors
Find your way into NuPulseCV
Sign up to find every way you can get introduced to NuPulseCV
- Your email: who you already know at NuPulseCV, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the NuPulseCV team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
NuPulseCV develops the Voyage device, a cardiac support technology aimed at patients with heart failure who are treated at both major institutions and community hospitals. The company is guided by a scientific advisory board of clinically active cardiologists and cardiac surgeons.
Founders & leadership
NuPulseCV was founded in 2010 by VALLUVAN JEEVANANDAM.
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$14.2M disclosed across 3 rounds · 2014–2020
▶$2.1MraisedMar 2020 · 2 investors · BiotechnologyRule 506(b)
- Douglas AltschulerExecutive Officer, Director
- Richard ShermanDirector
- Brian NovackDirector
- Alex ShlyankevichDirector
- Greg ScottDirector
- Dirk SimmonsDirector
- Sonna Patel-RamanExecutive Officer
- Offering amount
- $20M
- Amount sold
- $2.1M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.4MraisedJul 2018 · 13 investors · BiotechnologyRule 506(b)
- GREG SCOTTDirector
- RICHARD SHERMANDirector
- ALEX SHLYANKEVICHDirector
- SONNA PATEL-RAMANExecutive Officer
- DOUGLAS ALTSCHULERExecutive Officer, Director
- BRIAN NOVAKDirector
- Offering amount
- $25M
- Amount sold
- $5.4M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedAug 2014 · 13 investors · BiotechnologyRule 506(b)
- BRIAN NOVACKDirector
- RICHARD SHERMANDirector
- VALLUVAN JEEVANANDAMDirector
- DOUGLAS ALTSCHULERExecutive Officer, Director
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- Minimum investment
- $150K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $256.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does NuPulseCV do?
- NuPulseCV develops the Voyage device, a cardiac support technology aimed at patients with heart failure who are treated at both major institutions and community hospitals. The company is guided by a scientific advisory board of clinically active cardiologists and cardiac surgeons.
- Who founded NuPulseCV?
- NuPulseCV was founded by VALLUVAN JEEVANANDAM in 2010.
- Who are NuPulseCV's investors?
- NuPulseCV's investors include Broadview Ventures.
- How much funding has NuPulseCV raised?
- NuPulseCV has disclosed $14.2M raised across 3 rounds.
- Where is NuPulseCV headquartered?
- NuPulseCV is headquartered in Raleigh, US.